NKTR Competitors & Alternatives
Compare Nektar Therapeutics with similar stocks in the same industry
Biotechnology
NKTR
Main Stock$68.32
Tradestie Score
59
Market Cap
$1.12B
Revenue Growth
0.0%
Analyst Upside
+124.3%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$31.00
|
$2.44B | - | 49 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$59.31
|
$2.42B | - | 54 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$147.03
|
$2.41B | - | 60 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$36.15
|
$2.40B | - | 57 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$27.12
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$133.82
|
$2.35B | - | 57 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.79
|
$2.34B | - | 54 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$75.98
|
$2.33B | - | 64 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$40.55
|
$2.33B | - | 59 | Compare |
More NKTR Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry